Drug Discovery and Therapy

National Cancer Institute (NCI) provides preclinical cancer research, which includes evaluating the preclinical safety and pharmacokinetics of chemotherapeutics and chemopreventive agents. Many research Laboratories also provides genetic toxicology testing for NCI's chemoprevention program, synthesizes compounds for NCI's carcinogen repository, and manufactures clinical trial materials.

National Cancer Institute (NCI) funded for Tumour Glycome Laboratories. They are the principal component of the trans-NIH Alliance of Glycobiologists for Detection of Cancer and Cancer Risk, which is searching for glycan-based biomarkers for breast, ovarian, lung, prostate and pancreatic cancers and melanoma.

More than 30 years of research has led to numerous drugs on the market or ready for licensing, including:

·         Targretin® (bexarotene), a retinoid receptor ligand marketed by Eisai

·         Tirapazamine, a hypoxic tissue-selective cytotoxin

·         TAS-108, a selective estrogen receptor modulator licensed to Taiho Pharmaceutical

·         PDX (pralatrexate), an antimetabolite licensed to Allos Therapeutics

·         SR16157, a dual estrone sulfatase / ER antagonist for breast cancer treatment

  • Anti-Cancer Drug Discovery and Therapy
  • CVS Drug Discovery and Therapy
  • Innovative Drug Discovery and Nanotechnology
  • Anti-Infectives Drug Discovery and Therapy
  • CNS Drug Discovery and Therapy
  • Anti- Diabetic Drug Discovery and Therapy
  • Application of Nanotechnology in Pharmaceutical Formulation Design and Development

Related Conference of Drug Discovery and Therapy

January 27-28, 2025

25th World Congress on Medicinal Chemistry and Drug Design

Bangkok, Thailand
March 13-14, 2025

2nd International Conference on Drug Discovery and Development

Prague, Czech Republic
April 07-08, 2025

15th World Congress on Chemistry

Vancouver, Canada
May 14-15, 2025

17th International Conference on Clinical Chemistry

Toronto, Canada
June 25-26, 2025

15th World Congress on Analytical & Bioanalytical Techniques

Aix-en-Provence, France
June 26-27, 2025

14th World Congress on Chromatography

Paris, France
August 18-19, 2025

14th World Congress on Biopolymers and Biomaterials

Valencia, Spain
September 22-23, 2025

21st European Organic Chemistry Congress

Dubai, UAE
October 27-28, 2025

15th International Chemistry Congress

London, UK
December 08-09, 2025

5th International Conference on Analytical Chemistry

Rome, Italy
September 13 - 16 2015

Medicinal Chemistry

Cambridge United Kingdom
October 13 - 16 2015

Chemistry of Antibiotics and other Bioactive Compounds

Texas USA
November 09 - 11 2015

Functional Analysis Screening Technologies

Boston United States
November 10 2015

Fibrosis Disease medicinal chemistry progress from biological target to the clinic

Slough United Kingdom
February 15th - 18th 2016

Drug Discovery and Therapy

Sharjah UAE
April 20 - 21 2016

Fragment-Based Drug Discovery From Hits to Leads and Lessons Learned

San Diego CA USA North America
June 13 - 17 2016

QSAR in Environmental and Health Sciences

Florida USA
September 20 - 23 2016

Alternatives to Animal Testing

University of Linz Austria
November 10 - 12 2016

Recent Trends in Drug Development

Muscat Oman
August 27 - September 01 2017

Theoretical and Computational Chemists

Munich Germany

Drug Discovery and Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in